Evidence map›Paper›PMID 27698446›Full record

ArticleLeukemia2017

Expansion of Th

T Harada, H Miki, Q Cui, A Oda, R Amachi, J Teramachi, A Bat-Erdene, K Sogabe, M Iwasa, S Fujii and 8 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

T HaradaDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
H MikiDivision of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan.
Q CuiDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
A OdaDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
R AmachiDepartment of Orthodontics and Dentofacial Orthopedics, The University of Tokushima Graduate School of Oral Science, Tokushima, Japan.
J TeramachiDepartment of Histology and Oral Histology, The University of Tokushima Graduate School of Oral Science, Tokushima, Japan.
A Bat-ErdeneDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
K SogabeDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
M IwasaDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
S FujiiDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
S NakamuraDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
K KagawaDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
S YoshidaDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
I EndoDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
K AiharaDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
S OzakiDepartment of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
T MatsumotoFujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima, Japan.
M AbeDepartment of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsCell ProliferationDiphosphonatesHumansImidazolesImmunologic FactorsLenalidomideMultiple MyelomaTh1 CellsThalidomideT-LymphocytesZoledronic AcidDiphosphonatesImidazolesImmunologic FactorsLenalidomidepomalidomideThalidomideZoledronic Acid

Identifiers

PMID27698446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.